Oliver Hartmann
Hennigsdorf, BB 16761, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1-7), in Acute Heart Failure: Insights from the PUSH-AHF trial.
Journal: Journal of cardiac failure
Published: July 10, 2026
Circulating DPP3 limits efficacy of angiotensin II infusion in septic shock.
Journal: Critical care (London, England)
Published: March 10, 2026
Cardiogenic shock supported with VA-ECMO: Association between cDPP3 concentrations and outcomes in a post hoc analysis of the ADRECMO cohort.
Journal: Journal of cardiac failure
Published: March 02, 2026
Clinical utility of proenkephalin A 119-159 for prediction of worsening renal function and prognosis in patients with sepsis -results of a patient-level meta-analysis.
Journal: Critical care (London, England)
Published: January 13, 2026
cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies.
Journal: ESC heart failure
Published: November 25, 2025
Correction: Kinetics of adrenomedullin pathway activation in a porcine sepsis model and a human cohort of sepsis and septic shock.
Journal: Scientific reports
Published: November 04, 2025
Proenkephalin A 119-159 in Kidney Transplantation: A Novel Biomarker for Superior Tracking of Graft Function Trajectories.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: January 19, 2025
Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD.
Journal: Atherosclerosis
Published: December 04, 2024
Targeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer.
Journal: The EMBO journal
Published: November 22, 2024
Last Updated: 09/26/2026